SEC Form 4 · accession 0001368993-16-000073
WaferGen Bio-systems, Inc. · WGBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael P Henighan
Officer — Chief Financial Officer
Period of report
Jan 22, 2016
Accepted (ET)
Jan 27, 2016 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001368993
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.56 | Jan 22, 2016 | A | 50,000 | A | — | Jan 22, 2023 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1One third of the Shares subject to the Option shall vest on each of the first three anniversaries of the Vesting Commencement Date, such that 100% of the Shares subject to the Option shall be fully vested three (3) years after the Vesting Commencement Date